Changes in Epidemiology in Pediatric Invasive Group A Streptococcal Infections in Ireland During the 2022-2023 Outbreak
- PMID: 40106787
- DOI: 10.1097/INF.0000000000004746
Changes in Epidemiology in Pediatric Invasive Group A Streptococcal Infections in Ireland During the 2022-2023 Outbreak
Abstract
Background: From October 2022 to June 2023, there was a 4-fold increase in pediatric invasive group A streptococcus cases (iGAS) in the Republic of Ireland. This project aimed to better understand the clinical characteristics and disease course of iGAS in children in Ireland to inform Public Health interventions and messaging for carers, clinicians and the public.
Methods: All cases of iGAS notified to Public Health under 16 years from October 2022 to June 2023 inclusive were collated. A clinical case review of every death and hospitalization was performed under the auspices of the National Incident Management team using an online questionnaire. Analysis was performed using a 2-sided Fischer's exact test and 1-way analysis of variance.
Results: Of 180 cases of iGAS in children, 167 had clinical data collected; 33 of 49 with skin and soft tissue infection had active varicella, and 69 of 167 had at least 1 respiratory viral coinfection. Seventy-four of 167 required therapeutic procedural intervention, and 34 of 167 required pediatric intensive care unit admission. Ten of 12 patients who died had necrotizing pneumonia, and 8 had an out-of-hospital cardiac arrest. Compared with historical data, significant changes in iGAS epidemiology in children were seen, with an increase in respiratory diagnoses, a decrease in musculoskeletal disease and an increased need for procedural intervention.
Conclusions: The rapidity and severity of secondary deterioration and death in children with iGAS highlight the importance of sepsis awareness in primary and secondary care. The high prevalence of viral coinfection emphasizes the importance of current vaccine uptake and expansion of the national schedule to include varicella zoster virus.
Keywords: invasive group A streptococcus; outbreak; pediatric iGAS.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Bryant A, Stevens D. Streptococcus pyogenes . In: Mandell D. Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Saunders; 2020:2446.
-
- Health Protection Surveillance Centre. Report on Invasive Group A Streptococcal (iGAS) Infections in Ireland. HPSC. 2023.
-
- Nygaard U, Hartling UB, Munkstrup C, et al. Invasive group A streptococcal infections in children and adolescents in Denmark during 2022–23 compared with 2016–17 to 2021–22: a nationwide, multicentre, population-based cohort study. Lancet Child Adolesc Health. 2023;8:112–121.
-
- Schöbi N, Duppenthaler A, Horn M, et al. Preadmission course and management of severe pediatric group A streptococcal infections during the 2022–2023 outbreak: a single-center experience. Infection. 2024;52:1397–1405.
-
- Cobo-Vázquez E, Aguilera-Alonso D, Carrasco-Colom J, et al. Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Eur. 2023;27:100597.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
